ESC 365 - Ms Elisavet Angeli

Speaker illustration

Ms Elisavet Angeli

Nordic Bioscience, Herlev (Denmark)

Member of:

Heart Failure Association

Endotrophin, quantified by a novel assay, is prognostic of all-cause mortality in two different cohorts of patients with heart failure with preserved ejection fraction

Event: Heart Failure 2025

Topic: Biomarkers

Session: Pathophysiology, detection and biomarkers

A biomarker of collagen type I is associated with risk of mortality after ST-elevated myocardial infarction

Event: Heart Failure 2023

Topic: Pathophysiology and Mechanisms

Session: Heart failure - multi-topics 1

Type III collagen formation is significantly associated with risk of outcome in HFpEF patients but loses its significant association with underlying AF

Event: ESC Congress 2022

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session: Chronic heart failure and atrial fibrillation

Serum PRO-C3, a biomarker of type III collagen formation, is increased in heart failure patients of different aetiologies and can be predictive of outcome

Event: Heart Failure 2022

Topic: Biomarkers

Session: Heart Failure ePosters - focus on Chronic Heart Failure 7

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources